Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Healthcare Copper
Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Medivolve Inc > My opinion: HUGE ERROR in listing on NEO
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(274)
•••
Comment by Jasper66on Oct 16, 2020 2:21pm
140 Views
Post# 31729501

RE:RE:My opinion: HUGE ERROR in listing on NEO

RE:RE:My opinion: HUGE ERROR in listing on NEO
Very good insight Holdme. The move to NEO seems to be a strategic move to release news to the US. After all, if your planning 2000 testing sites in the United States, then you better have a way to deciminate the news in the U.S. A lot has to do with our share price also. I'm sure Qsc management are keenly aware how this stock keeps on being held down. The changeover to NEO hopefully will slow the shorting. Once the share price rises, Qsc will most likely look at another stock exchange in the U.S.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities